Syncona CEO On Why Its 10th Start-Up Focuses On T-Regulatory Cell Therapies

 
• By Sten Stovall
  
T cells
Syncona founded Quell Therapeutics with £35m Series A Financing • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip